House Bill 2510 would have set up a means for the attorneys in the lawsuit against pharmaceutical companies to tap into the Oklahoma Opioid Abatement Revolving Fund to be reimbursed for fees. Governor Kevin Stitt vetoed that bill.
“House Bill 2510 amends that Political Subdivisions Opioid Abatement Grants Act to allow grant awards from the Oklahoma Opioid Abatement Revolving Fund to be used to reimburse attorney fees, provided the legal services agreement was entered into before May 21, 2020. This is a highly improper use of state resources. The Abatement Fund is rightfully designed to help Oklahomans harmed by opioid addiction-not pay attorneys who have already been compensated for their efforts in suing pharmaceutical companies.
For these reasons, I have vetoed House Bill 2510,” Stitt wrote in his veto message.
